Cookie Policy
We value the protection of our users' privacy and our cookie usage policy. Our website uses cookies and other similar technologies to distinguish you from other users of our website. This helps us to provide you with a good experience when you browse our website and helps us to improve the quality of our service. For more information, please click and see our Cookie Policy.

About Us

Company Profile

Zybio Inc. is a high-tech enterprise specialized in R&D, manufacture, sales and technical services of in vitro diagnostic reagents and equipment, with the headquarter and manufacturing center located in Dadukou District, Chongqing.

Zybio has more than 3,300 employees worldwide, of which R&D personnel account for more than 30% . Nearly 50% of R&D personnel have master's degree or above. The company compared to spend no less than 15% of sales revenue on its research and development.

As a postdoctoral programme, Zybio is dedicated to attract more talents to focus on the cutting-edge technology in IVD field and take product research and development as the core driving force in the future’s continuous and rapid development. We have established several R&D centers distributed in China, like Chongqing R&D center, Beijing R&D center, Guangzhou R&D center, Shenzhen R&D center, Nanjing R&D center Xiamen R&D center and Changchun R&D center . The company’s main product covers clinical chemistry, immunoassay, molecular diagnosis, POCT, hematology, microbiology, pathological and other diagnostic products. It also has a comprehensive layout in core technical fields such as biological raw materials and chemical raw materials. The company has developed a wide range of core technologies such as genetic engineering antigens/antibodies, diagnostic nanomaterials, high-precision diagnostic equipment and core component, multiple label signal amplification, and rapid nucleic acid extraction and detection.

Till now, we have obtained nearly 500 product registration certificates and nearly 60 invention patents. Zybio officially established a standardized reference measurement laboratory in 2018 and some key clinical chemistry items have passed the quality evaluation of International Federation of Clinical Chemistry and Laboratory Medicine (IFCC-RELA).

Zybio has 100,000 m2 manufacture plant, equipped with a modern qualified production workshop, and has 19 production lines including reagents and equipment. We have setup an international standard quality system and our products have passed ISO 90001 and ISO 13485. All products have passed strict quality inspection before shipping. The current production capacity can reach 3.0 billion kits of reagent and 35,000 equipment per year.

Zybio has became a leading enterprise in the field of medical equipment and one of the top 100 manufacturing enterprise in Chongqing. In order to provide comprehensive service for our customers, Zybio has developed broad marketing system worldwide. In China, we have established 79 service teams across 31 provinces, with the service ability of "1 hour response, 12 hours on-site ". Also, we have set up local marketing service system in overseas. Until now, our products have been sold to over 100 countries, including Asia, South America, North America, Europe and Africa. Our products and solutions are applied in more than 13,000 hospitals worldwide.

"Dedication To Accuracy", Zybio will continue to meet the various needs of customers, focus on innovation in IVD industry. We would cooperate deeply with global medical institutions to create greater value for customers and continuously strive for creating an international superb IVD brand!